Quinn: From rich list to risk of bankruptcy

FOUR years ago Seán Quinn was Ireland’s richest man. Now he faces the prospect of bankruptcy.

Quinn: From rich list to risk of bankruptcy
Fri, 15 Apr, 2011 - 01:00
Niamh Hennessy

Mr Quinn and his family owe Anglo Irish Bank almost €2.9 billion and the bank has moved to oust him from the company he founded.

It is estimated that at least €2bn of what the Quinn family owes Anglo could be written off.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Explosion at Donegal service station Planning granted for new petrol station next to site of Creeslough tragedy
Michael Lyster remembered as ‘magic in human form’ at emotional memorial service Michael Lyster remembered as ‘magic in human form’ at emotional memorial service
AI prompt chat bot. Search website to generate data, text or image. Man using computer with artificial intelligence app. Virtual Mental health experts issue warning over AI 'therapy'
CourtsPlace: IrelandPlace: USPlace: BritainPerson: QuinnPerson: Sean QuinnPerson: Finance MinisterPerson: Michael NoonanPerson: Mike AynsleyPerson: AynsleyPerson: Bill HolohanPerson: Director of Corporate EnforcementPerson: Kieran WallacePerson: Pat O’NeillOrganisation: Anglo Irish BankOrganisation: AngloOrganisation: Quinn Group (ROI) LtdOrganisation: Quinn GroupOrganisation: Liberty MutualOrganisation: Quinn InsuranceOrganisation: KPMG
<p>Sodium valproate, manufactured by Sanofi and sold as Epilim, has been linked to a high risk of serious injury for babies in the womb. File picture</p>

Three more children settle Epilim sodium valproate cases

READ NOW

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited